We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $214M
1-Year Est. Return 18.82%
This Fund
S&P 500
This Quarter Est. Return
+7.82%
1 Year Est. Return
+18.82%
3 Year Est. Return
+59.8%
5 Year Est. Return
+72.92%
10 Year Est. Return
+638.85%
AUM
$469M
AUM Growth
+$24.2M
Cap. Flow
-$618K
Cap. Flow %
-0.13%
Top 10 Hldgs %
20.39%
Holding
391
New
176
Increased
55
Reduced
72
Closed
70

Top Buys

Rank Stock Value
1
BEN icon
Franklin Resources
BEN
+$8.93M
2
WAT icon
Waters Corp
WAT
+$8.75M
3
TEL icon
TE Connectivity
TEL
+$8.55M
4
LRCX icon
Lam Research
LRCX
+$8.42M
5
CBOE icon
Cboe Global Markets
CBOE
+$4.84M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$8.14M
2
BAC icon
Bank of America
BAC
+$7.43M
3
NVDA icon
NVIDIA
NVDA
+$6.77M
4
CIM
Chimera Investment
CIM
+$6.72M
5
COST icon
Costco
COST
+$5.74M

Sector Composition

Rank Sector Weight
1 Technology 20.05%
2 Financials 14.96%
3 Healthcare 13.47%
4 Consumer Discretionary 11.37%
5 Industrials 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AET
276
DELISTED
Aetna Inc
AET
$3K ﹤0.01%
+22
New +$3.11K
AME icon
277
Ametek
AME
$57.6B
$2K ﹤0.01%
+35
New +$2.06K
AMP icon
278
Ameriprise Financial
AMP
$49.5B
$2K ﹤0.01%
+14
New +$1.78K
CLB icon
279
Core Laboratories
CLB
$513M
$2K ﹤0.01%
+23
New +$2.48K
CVS icon
280
CVS Health
CVS
$123B
$2K ﹤0.01%
+28
New +$2.21K
EXPE icon
281
Expedia Group
EXPE
$36.8B
$2K ﹤0.01%
+13
New +$1.82K
GM icon
282
General Motors
GM
$76.3B
$2K ﹤0.01%
+67
New +$2.27K
HCA icon
283
HCA Healthcare
HCA
$88.5B
$2K ﹤0.01%
+26
New +$2.2K
HIG icon
284
Hartford Financial Services
HIG
$39.6B
$2K ﹤0.01%
+39
New +$1.93K
PPLI
285
People Inc
PPLI
$3.2B
$2K ﹤0.01%
+84
New +$1.43K
JBLU icon
286
JetBlue
JBLU
$2.34B
$2K ﹤0.01%
+77
New +$1.69K
LH icon
287
Labcorp
LH
$25.6B
$2K ﹤0.01%
+13
New +$1.59K
MAA icon
288
Mid-America Apartment Communities
MAA
$15.5B
$2K ﹤0.01%
+20
New +$2.06K
MLM icon
289
Martin Marietta Materials
MLM
$32.3B
$2K ﹤0.01%
+7
New +$1.58K
PCG icon
290
PG&E
PCG
$37.4B
$2K ﹤0.01%
+27
New +$1.82K
RLI icon
291
RLI Corp
RLI
$5.91B
$2K ﹤0.01%
+74
New +$2.08K
SLM icon
292
SLM Corp
SLM
$5.15B
$2K ﹤0.01%
+139
New +$1.58K
SYF icon
293
Synchrony
SYF
$25.6B
$2K ﹤0.01%
+69
New +$2.05K
SYY icon
294
Sysco
SYY
$40.4B
$2K ﹤0.01%
+45
New +$2.4K
VLO icon
295
Valero Energy
VLO
$87.2B
$2K ﹤0.01%
33
-59,052
-100% -$3.83M
VNO icon
296
Vornado Realty Trust
VNO
$7.27B
$2K ﹤0.01%
+20
New +$1.55K
ZBH icon
297
Zimmer Biomet
ZBH
$18.8B
$2K ﹤0.01%
+15
New +$1.78K
DISH
298
DELISTED
DISH Network Corp.
DISH
$2K ﹤0.01%
26
-73,904
-100% -$4.66M
ACGL icon
299
Arch Capital
ACGL
$33.9B
$1K ﹤0.01%
+33
New +$1.05K
AJG icon
300
Arthur J. Gallagher & Co
AJG
$64.5B
$1K ﹤0.01%
+12
New +$678

Similar funds

C.M. Bidwell & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, C.M. Bidwell & Associates held 391 positions worth $469M, up 5.4% from $444M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

C.M. Bidwell & Associates's Q2 2017 filing shows 176 new, 55 increased, 72 reduced and 70 closed positions. Its largest new stake was Franklin Resources: 208,945 shares worth $9.36M. The largest sale was Goldman Sachs, an estimated $8.14M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

  • C.M. Bidwell & Associates's largest Q2 2017 buy was Franklin Resources: 208,945 shares worth $9.36M.
  • C.M. Bidwell & Associates added most to Baxter International in Q2 2017, an estimated $4.83M increase.
  • C.M. Bidwell & Associates's biggest Q2 2017 reduction was Goldman Sachs, cutting an estimated $8.14M.
  • C.M. Bidwell & Associates fully exited Chimera Investment in Q2 2017, selling an estimated $6.72M.
  • C.M. Bidwell & Associates's ten largest holdings make up 20% of its $469M portfolio in Q2 2017.
  • C.M. Bidwell & Associates opened 176 new positions and closed 70 in Q2 2017.
  • C.M. Bidwell & Associates's portfolio value rose 5.4% quarter-over-quarter to $469M.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.